MX2017016479A - Composicion de bebidas sinergicas. - Google Patents

Composicion de bebidas sinergicas.

Info

Publication number
MX2017016479A
MX2017016479A MX2017016479A MX2017016479A MX2017016479A MX 2017016479 A MX2017016479 A MX 2017016479A MX 2017016479 A MX2017016479 A MX 2017016479A MX 2017016479 A MX2017016479 A MX 2017016479A MX 2017016479 A MX2017016479 A MX 2017016479A
Authority
MX
Mexico
Prior art keywords
stress
alcohol
sugar
veisalgia
beverage composition
Prior art date
Application number
MX2017016479A
Other languages
English (en)
Inventor
Chigurupati Harsha
Radheshyam BIYANI Manish
AUDDY Biswajit
Chakrabarti Shrabana
Original Assignee
Chigurupati Harsha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chigurupati Harsha filed Critical Chigurupati Harsha
Publication of MX2017016479A publication Critical patent/MX2017016479A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención describe una composición de bebida sinérgica para aliviar el estrés oxidativo inducido por el alcohol, el estrés hepático, el estrés del SNC, la veisalgia y los parámetros de inmunología modulante. La composición comprende glucósido de saponina, derivado de aminoácido y azúcar o alcohol de azúcar como ingredientes activos y agentes que ajustan el pH y agentes aromatizantes como ingredientes inactivos. Las proporciones calculadas de derivados de aminoácidos, glucósido de saponina y azúcar o alcohol de azúcar en el alcohol exhiben efectos sinérgicos, aliviando así el estrés oxidativo, estrés hepático, estrés del SNC, veisalgia y parámetros inmunológicos moduladores, que en última instancia pueden conducir a la prevención del daño inducido por el alcohol o deterioro de los órganos, que podría ser temporal o permanente.
MX2017016479A 2015-06-19 2016-06-18 Composicion de bebidas sinergicas. MX2017016479A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3070CH2015 2015-06-19
PCT/IN2016/050189 WO2016203499A1 (en) 2015-06-19 2016-06-18 Synergistic beverage composition

Publications (1)

Publication Number Publication Date
MX2017016479A true MX2017016479A (es) 2018-08-15

Family

ID=56738145

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016479A MX2017016479A (es) 2015-06-19 2016-06-18 Composicion de bebidas sinergicas.

Country Status (9)

Country Link
US (1) US10456359B2 (es)
EP (1) EP3310191A1 (es)
JP (1) JP2018517782A (es)
CN (1) CN107920577A (es)
AU (1) AU2016280877A1 (es)
CA (1) CA2989743A1 (es)
EA (1) EA201800027A1 (es)
MX (1) MX2017016479A (es)
WO (1) WO2016203499A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216813A1 (en) * 2016-06-18 2017-12-21 Chigurupati Harsha Composition to reduce dna and hepatic damage and to enhance repair thereof
WO2018061020A1 (en) * 2016-09-30 2018-04-05 Chigurupati Harsha A composition for dna protection
WO2019131444A1 (ja) * 2017-12-26 2019-07-04 花王株式会社 認知機能改善剤
CN114786689A (zh) * 2019-11-18 2022-07-22 雀巢产品有限公司 用于在脑健康中使用的谷胱甘肽增强的组合物和方法
US20230193555A1 (en) * 2020-04-14 2023-06-22 Cikman Mustafa Cueneyt Antibacterial and antiviral fabric
CN113069527B (zh) * 2021-04-20 2022-03-18 北京华睿鼎信科技有限公司 一种具有解酒保肝功能的组合物及其制备方法
CN113750167A (zh) * 2021-10-22 2021-12-07 安徽科技学院 一种解酒保肝护胃组合物
CN118542864B (zh) * 2024-07-26 2024-11-26 广东海洋大学 一种缓解动脉粥样硬化的肌肽组合物及其应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107605A (en) * 1960-09-23 1963-10-22 Colonial Sugar Refining Co Extracting sucrose from sugar cane
JPS614746A (ja) 1984-06-19 1986-01-10 Sakai Chem Ind Co Ltd 塩素含有樹脂組成物
JPS6150917A (ja) 1984-08-20 1986-03-13 Ajinomoto Co Inc 抗アルコ−ル性肝障害組成物
JPH0614746B2 (ja) 1984-09-13 1994-02-23 株式会社東芝 Ｘ線画像処理装置
EP0502554A3 (en) 1986-05-15 1993-03-10 Emory University Composition comprising an oxygen radical scavenger and a surfaceactive copolymer
JPS6336773A (ja) 1986-07-29 1988-02-17 Nippon Oil & Fats Co Ltd アルコ−ル飲料
WO1989004165A1 (en) 1987-10-19 1989-05-18 Haklitch Joseph A Detoxifying food supplement
JPH01216924A (ja) 1988-02-24 1989-08-30 Ajinomoto Co Inc 肝障害治療剤
JPH0614746A (ja) * 1992-06-29 1994-01-25 Oomiya Yakugyo Kk 健康飲料
US6099844A (en) * 1994-08-22 2000-08-08 Triarco Industries, Inc. Increasing yield of extractable substances from botanicals with an enzyme composition
JP2000072669A (ja) 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物
AT411958B8 (de) * 1998-11-19 2004-09-27 Jhs Privatstiftung Erfrischungsgetränk zur steigerung der alkohol-abbau-kapazität
KR100318223B1 (ko) 1999-07-05 2001-12-22 김찬식 페피노 추출물을 함유하는 혈중알콜농도 저하용 조성물 및 그 제조방법
WO2002017939A1 (en) 2000-08-31 2002-03-07 Council Of Scientific And Industrial Research A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra
US6855526B2 (en) * 2002-05-15 2005-02-15 The United States Of America As Represented By The Secretary Of Agriculture Method for making mannitol with Lactobacillus intermedius
CN1586489A (zh) 2004-07-14 2005-03-02 李�杰 复方甘草酸盐胶囊剂和颗粒剂及其制备方法
CN1706394A (zh) 2005-05-08 2005-12-14 余世春 注射用复方甘草酸单铵s制剂、制备方法及质量控制技术
CN1709272A (zh) 2005-06-15 2005-12-21 张哲峰 一种甘草酸二铵的组合药物及其制备方法
CN100539877C (zh) 2005-07-05 2009-09-16 黄恒燊 解酒保肝饮料及其制备方法
CN1985987B (zh) 2005-12-19 2010-05-12 山东轩竹医药科技有限公司 甘草酸或其盐和还原型谷胱甘肽的药物组合物
JP5025491B2 (ja) * 2006-01-13 2012-09-12 株式会社明治 抗炎症組成物および抗炎症組成物の製造法
JPWO2007119503A1 (ja) 2006-03-23 2009-08-27 協和発酵バイオ株式会社 寝起き改善剤
JP2008266203A (ja) 2007-04-19 2008-11-06 Bussan Food Science Kk 活性酸素種消去酵素群の活性を向上させる方法
CN101332289A (zh) 2007-06-26 2008-12-31 李海齐 一种醒酒保肝的保健品及其制备方法
US20090162483A1 (en) * 2007-12-20 2009-06-25 Wendy Lynn Constantine Sports beverage and method of making
CN101633683B (zh) 2008-07-26 2013-09-25 刘力 抗肝炎药物及其制备和用途
US20100086666A1 (en) 2008-10-03 2010-04-08 Andrew Adelman Alcoholic beverage
CN101669962A (zh) 2009-09-18 2010-03-17 杭州市第六人民医院 复合甘草酸氨基酸注射液及其制备方法和应用
WO2012027603A2 (en) * 2010-08-26 2012-03-01 Clarity Products, Limited Liability Company Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
CN102450714A (zh) * 2010-10-22 2012-05-16 赵强 一种解酒饮料及其制备方法
CN102302502A (zh) 2011-06-30 2012-01-04 北京秦武田制药有限公司 一种复方甘草酸苷制剂及其制备方法
CN103622981A (zh) 2012-08-27 2014-03-12 康阳润和（北京）医药科技有限公司 复方甘草酸苷口服液体制剂及其制备方法
JP6194412B2 (ja) 2013-04-29 2017-09-06 ハーシャ チグルパティ アルコール飲料の毒性低減
CN103404934B (zh) 2013-08-24 2015-07-01 江苏阜丰生物科技有限公司 一种含谷氨酰胺的解酒固体饮料及其制备方法
CN103445175B (zh) 2013-09-17 2014-10-08 深圳万和制药有限公司 具有解酒保肝作用的组合物

Also Published As

Publication number Publication date
AU2016280877A1 (en) 2018-01-25
WO2016203499A4 (en) 2017-02-23
US10456359B2 (en) 2019-10-29
EA201800027A1 (ru) 2018-06-29
US20160367478A1 (en) 2016-12-22
JP2018517782A (ja) 2018-07-05
CA2989743A1 (en) 2016-12-22
EP3310191A1 (en) 2018-04-25
WO2016203499A1 (en) 2016-12-22
CN107920577A (zh) 2018-04-17

Similar Documents

Publication Publication Date Title
MX2017016479A (es) Composicion de bebidas sinergicas.
AR124510A2 (es) Métodos para elaborar composiciones de glucósidos de esteviol glucosilados y composiciones edulcorantes que las comprenden
NZ734599A (en) Compositions of steviol multiglycosylated derivatives and stevia components
PH12019550249A1 (en) Solid compositions for oral administration
EP3232817A4 (en) Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
WO2012156531A3 (en) Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of inflammatory diseases or conditions
WO2013039365A3 (ko) 지소화성 성분을 함유하는 당뇨 개선용 감미 소재 조성물
MX387817B (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
WO2014159628A3 (en) Preventing or delaying chill injury response in plants
MX2024009298A (es) Composiciones que comprenden rebaudiosido j
MY190181A (en) Steviol glycoside compositions for oral ingestion or use
PH12017501003B1 (en) Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
MY192153A (en) Steviol glycoside composition
MX2023004432A (es) Composiciones de glicosido de esteviol.
MX2017016588A (es) Novedosos glucosidos de triterpeno como edulcorantes o potenciador de edulcorante.
WO2012084423A3 (de) Wirkstoffkombinationen aus glucosylglyceriden und einem oder mehreren milden tensiden
WO2017040407A8 (en) Compositions and methods for the reduction or prevention of non-alcoholic steatohepatitis (nash)
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
WO2016159524A3 (ko) 인삼 열매 추출물을 포함하는 난소 노화 개선용 조성물
HK1222336A1 (zh) 包含胆硷及其衍生物的组合物、其用途以及其制备方法
WO2014145126A3 (en) Methods of treating dyskinesia and related disorders
EA201890202A1 (ru) Природные стильбены в качестве подсластителей или усилителей сладости
PH12018000227B1 (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
MX2018007241A (es) Composiciones de glicosido de esteviol.
WO2017042198A3 (en) Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders